Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
FMR 12.47M $58.60M March 31, 2014
Deerfield Management Company 12.21M $57.37M March 31, 2014
T. Rowe Price Associates 8.97M $42.16M March 31, 2014
BVF 8.49M $39.89M March 31, 2014
OrbiMed Advisors 6.30M $29.60M March 31, 2014
STATE STREET CORPORATION 5.52M $25.93M March 31, 2014
BlackRock Fund Advisors 4.99M $23.47M March 31, 2014
Redmile 4.88M $22.95M March 31, 2014
TimesSquare Capital Management 3.93M $18.46M March 31, 2014
Vanguard 3.91M $18.36M March 31, 2014
BlackRock Institutional Trust Company, N.A. 3.75M $17.64M March 31, 2014
Artal Group S.A. 3.00M $18.66M Sept. 30, 2013
Gail Mannix 2.85M $13.40M March 31, 2014
Apex Capital 2.40M $11.28M March 31, 2014
GMT Capital 2.31M $14.38M Sept. 30, 2013
QVT Financial 2.26M $10.60M March 31, 2014
KOPP FUNDS 2.23M $11.17M Dec. 31, 2013
Kopp Investment Advisors 2.20M $10.35M March 31, 2014
Balyasny Asset Management 2.07M $9.73M March 31, 2014
Ulys 2.00M $6.80M March 31, 2012
Perceptive Advisors 1.93M $4.17M Dec. 31, 2011
Ridgeback Capital Investments 1.91M $11.16M Sept. 30, 2012
Perimeter Capital Partners 1.83M $6.79M Dec. 31, 2012
Cormorant Asset Management 1.75M $8.22M March 31, 2014
BlackRock Advisors 1.71M $8.04M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.70M $10.60M Sept. 30, 2013
Wellington Management Company 1.63M $5.57M March 31, 2012
Sectoral Asset Management 1.63M $9.49M Sept. 30, 2012
NORTHERN TRUST 1.59M $7.49M March 31, 2014
Baker Bros. Advisors 1.50M $7.51M Dec. 31, 2013

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M